<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Texas Heart Institute Journal"><meta name="citation_title" content="New Developments in Endovascular Interventions for Extracranial Carotid Stenosis"><meta name="citation_authors" content="Walter A. Tan, Chester R. Jarmolowski, Lawrence R. Wechsler, and  Mark H. Wholey"><meta name="citation_date" content="2000"><meta name="citation_issue" content="3"><meta name="citation_volume" content="27"><meta name="citation_firstpage" content="273"><meta name="citation_pdf_url" content="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=101079&amp;blobtype=pdf"><meta name="citation_abstract_html_url" content="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=101079&amp;rendertype=abstract"><meta name="citation_fulltext_html_url" content="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=101079"><meta name="citation_pmid" content="11093412"><meta name="DC.Title" content="New Developments in Endovascular Interventions for Extracranial Carotid Stenosis"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Texas Heart Institute"><meta name="DC.Contributor" content="Walter A. Tan"><meta name="DC.Contributor" content="Chester R. Jarmolowski"><meta name="DC.Contributor" content="Lawrence R. Wechsler"><meta name="DC.Contributor" content="Mark H. Wholey"><meta name="DC.Date" content="2000"><meta name="DC.Language" content="en"><link rel="stylesheet" href="corehtml/pmc/css/pmcstatic.css" type="text/css"><link rel="stylesheet" href="corehtml/pmc/css/pmcbase1.css" type="text/css"><link rel="stylesheet" href="corehtml/pmc/css/pmcbars-navy.css" type="text/css"><link rel="stylesheet" href="corehtml/pmc/css/pmcbody5.css" type="text/css"><link rel="stylesheet" href="corehtml/pmc/css/pmcrefs1.css" type="text/css"><script type="text/javascript" src="corehtml/pmc/js/common.js"></script><script type="text/javascript">window.name="mainwindow";</script><link href="http://www.ncbi.nlm.nih.gov/corehtml/jsutils/css/tileshop_pmc.1/tileshop_pmc.1.css" type="text/css" rel="stylesheet"><script type="text/javascript" src="http://www.ncbi.nlm.nih.gov/corehtml/jsutils/utils.1.js"></script><script>utils.jsLoader.sBase = "http://www.ncbi.nlm.nih.gov/corehtml/jsutils/";</script><script type="text/javascript" src="http://www.ncbi.nlm.nih.gov/corehtml/jsutils/tileshop_pmc.1/tileshop_pmc.1.js"></script><script type="text/javascript" src="http://www.ncbi.nlm.nih.gov/corecgi/tileshop/tileshop_data_db.1.js"></script><title>New Developments in Endovascular Interventions for Extracranial Carotid Stenosis</title></head><body class="pmc-body"><a id="top" name="top"></a><table cellpadding="0" cellspacing="0" width="100%" border="0"><tr valign="top"><td colspan="3"><table border="0" cellspacing="0" cellpadding="0" style="border-collapse: collapse;"><tr><td width="145" valign="top"><img src="corehtml/pmc/pmcgifs/pmc3_logo_v5.gif" border="0" usemap="#pmclogo" alt="pmc logo image"><map name="pmclogo"><area shape="rect" alt="Journal List" coords="65,52,137,67" href="fprender.fcgi"><area shape="rect" alt="Search" coords="7,52,52,67" href="redirect3.cgi?&amp;&amp;auth=0pEfTTwQvTARM8mxWAvRUHXqi_pwIQssDcQo2GA65&amp;reftype=other&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CLogo&amp;TO=Entrez%7CSearch%7CAll%20PMC&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pmc"><area shape="rect" alt="pmc logo image" coords="0,0,145,75" href="./"></map></td><td height="75" valign="top" style="padding-left: 4px;"><div><img align="top" border="0" src="corehtml/pmc/pmcgifs/logo-thij.gif" alt="Logo of thij" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,164,75" href="redirect3.cgi?&amp;&amp;auth=0VmkLkSD9OJN3EHKiE0wFNLU-Ii_lm3DnljSPZQ_I&amp;reftype=publisher&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN%2FA&amp;rendering-type=normal&amp;&amp;http://www.texasheartinstitute.org/Education/THIJournal/" alt="THI JOURNAL WEBSITE" target="pmc_ext" onclick="focuswin('pmc_ext')"><area shape="rect" coords="0,0,308,53" href="tocrender.fcgi?issn=0730-2347&amp;action=archive" alt="Current Issue."><area shape="rect" coords="309,0,499,53" href="tocrender.fcgi?issn=0093-3546&amp;action=archive" alt="See also Cardiovascular Diseases Journal in PMC."><area shape="rect" coords="165,57,333,75" href="redirect3.cgi?&amp;&amp;auth=0ZwVtEBCtah_cYNYaNd9PWBQfTb7qxw8IW2PXB5sb&amp;reftype=publisher&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN%2FA&amp;rendering-type=normal&amp;&amp;https://secure.texasheartinstitute.org/forms/THI-Journal-Subscription-Form.asp" alt="Subscribe" target="pmc_ext" onclick="focuswin('pmc_ext')"><area shape="rect" coords="334,57,500,75" href="redirect3.cgi?&amp;&amp;auth=0bGn1UkcloHSFn5aCeEUox0kZ7_bN5n0SxziAa5LF&amp;reftype=publisher&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN%2FA&amp;rendering-type=normal&amp;&amp;http://www.texasheartinstitute.org/Education/THIJournal/invitati.cfm" alt="Submissions" target="pmc_ext" onclick="focuswin('pmc_ext')"></map></div></td></tr></table></td></tr></table><table cellpadding="0" cellspacing="3" width="100%" border="0"><tr><td></td><td colspan="2"><div class="navlink-box navlink-box-gray"><a href="fprender.fcgi" class="navlink">Journal List</a><span> &gt; </span><a class="navlink" href="tocrender.fcgi?journal=92&amp;action=archive">Tex Heart Inst J</a><span> &gt; </span><a class="navlink" href="tocrender.fcgi?iid=2762">v.27(3); 2000</a></div></td></tr><tr><td width="145" valign="top" class="sidebar-cell"><div class="sidebar-article-navigation-box"><div class="sidefm-pmclink-item"><a href="articlerender.fcgi?artid=101079&amp;rendertype=abstract" class="sidefm-pmclink">Abstract</a></div><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>Full Text</a></div><div class="sidefm-pmclink-item"><a href="picrender.fcgi?artid=101079&amp;blobtype=pdf" class="sidefm-pmclink">PDF (479K)</a></div><div class="sidefm-pmclink-item"><a href="tocrender.fcgi?iid=2762" class="sidefm-pmclink">Contents</a></div><div class="sidefm-pmclink-item"><a href="tocrender.fcgi?journal=92&amp;action=archive" class="sidefm-pmclink">Archive</a></div></div><div class="sidebar-pubmed-box"><div class="sidebar-pubmed-links-to-box"><form name="pubmedLinks" onsubmit="return pubMedDbLinkSubmit(this)"><div class="sidefm-pmsubhead"><label for="pubmedOption">Related material:</label></div><select name="pubmedOption" id="pubmedOption" class="sidefm-pmart" onchange="return pubMedDbLinkSubmit(this)"><option value="redirect3.cgi?&amp;&amp;auth=0zMakypWusnCDb4LwDRu9ncwIZBk_LoUt9THmpAK_&amp;reftype=abs&amp;refto=entrez&amp;reffrom=sidebar&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article|Navigation&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/11093412">PubMed record</option><option selected value="redirect3.cgi?&amp;&amp;auth=0x7GZnDrz_XuhM5y1GTJqV4rY0DtF02ds6h_yYQlR&amp;reftype=relart&amp;refto=entrez&amp;reffrom=sidebar&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article|Navigation&amp;TO=Entrez|PubMed|Related%20Records&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Link&amp;dbFrom=PubMed&amp;from_uid=11093412">PubMed related arts</option><option value="redirect3.cgi?&amp;&amp;auth=00MEezieRAu_siEgKGBMWWIJ6jIBPWO0B47Ox45Wl&amp;reftype=linkout&amp;refto=entrez&amp;reffrom=sidebar&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article|Navigation&amp;TO=Entrez|PubMed|Linkout&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;Cmd=ShowLinkOut&amp;TermToSearch=11093412">PubMed LinkOut</option></select><br><input type="image" src="corehtml/pmc/pmcgifs/go.gif" alt="Go" class="sidefm-pmart"></form></div><div class="sidebar-pubmed-author-box"><div class="sidefm-pmsubhead">PubMed articles by:</div><div class="sidefm-pmclink-item"><a href="redirect3.cgi?&amp;&amp;auth=08OvmkLTXI-s1vnSqVFacd3vJVeQD27lyWMEkZ5vv&amp;reftype=authsrch&amp;refto=entrez&amp;reffrom=sidebar&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CNavigation&amp;TO=Entrez%7CPubMed%7CAuthor%20Search&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=PubMed&amp;term=%20Tan+WA%5Bauth%5D" class="sidefm-pmclink"> Tan, W.</a></div><div class="sidefm-pmclink-item"><a href="redirect3.cgi?&amp;&amp;auth=0RUZw7ejLOi477ISelY3l3CBlD0U1Mn6POXIZdAGE&amp;reftype=authsrch&amp;refto=entrez&amp;reffrom=sidebar&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CNavigation&amp;TO=Entrez%7CPubMed%7CAuthor%20Search&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=PubMed&amp;term=%20Jarmolowski+CR%5Bauth%5D" class="sidefm-pmclink"> Jarmolowski, C.</a></div><div class="sidefm-pmclink-item"><a href="redirect3.cgi?&amp;&amp;auth=0RYYxN48T38-oYnIVMbn2MIB0iLUkWHeC0aJ6sAnl&amp;reftype=authsrch&amp;refto=entrez&amp;reffrom=sidebar&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CNavigation&amp;TO=Entrez%7CPubMed%7CAuthor%20Search&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=PubMed&amp;term=%20Wechsler+LR%5Bauth%5D" class="sidefm-pmclink"> Wechsler, L.</a></div><div class="sidefm-pmclink-item"><a href="redirect3.cgi?&amp;&amp;auth=0NwYnAlS-pLXmpGnQrA6CLNbSKIRtTASkB20A65ji&amp;reftype=authsrch&amp;refto=entrez&amp;reffrom=sidebar&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CNavigation&amp;TO=Entrez%7CPubMed%7CAuthor%20Search&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=PubMed&amp;term=%20Wholey+MH%5Bauth%5D" class="sidefm-pmclink"> Wholey, M.</a></div></div></div></td><td rowspan="106" width="20px" height="300" background="corehtml/pmc/pmcgifs/wm-thij.gif"><div style="width:20px"></div></td><td valign="top" class="content-cell"><div class="front-matter-section"><table cellspacing="0" cellpadding="0" width="100%"><tr style="vertical-align: top"><td><div class="fm-citation"><div><span class="citation-abbreviation">Tex Heart Inst J. </span><span class="citation-publication-date">2000; </span><span class="citation-volume">27</span><span class="citation-issue">(3)</span><span class="citation-flpages">: 273–280. </span></div><div><span class="fm-vol-iss-date"> </span></div></div></td><td class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span>PMC101079</div></td></tr></table><div class="fm-copyright"><a class="int-reflink" href="about/copyright.html">Copyright</a>  2000 by the Texas Heart&#x000ae; Institute, Houston</div><div class="fm-title">New Developments in Endovascular Interventions for Extracranial Carotid Stenosis</div><div class="fm-author contrib-group">Walter A. Tan, MS, MD, Chester R. Jarmolowski, MD, Lawrence R. Wechsler, MD, and  Mark H. Wholey, MD<div class="fm-affl">Pittsburgh Vascular Institute, University of Pittsburgh Medical Center&#x02014;Shadyside (Drs. Tan, Jarmolowski, and Wholey) and University of Pittsburgh Medical Center&#x02014;Presbyterian (Dr. Wechsler), Pittsburgh, Pennsylvania<br></div></div><div class="fm-editor">Zvonimir Krajcer, MD, <span class="fm-role">Section Editor</span></div><div class="fm-footnote"></div></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);" style="text-transform: none;"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>Abstract</a></div><span style="text-transform: none;"></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id658881" class="sidefm-pmclink" style="text-transform: none;">Equipment</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id613982" class="sidefm-pmclink" style="text-transform: none;">Pharmacology</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614094" class="sidefm-pmclink" style="text-transform: none;">Technique</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614160" class="sidefm-pmclink" style="text-transform: none;">Patient Selection and Risk Stratification</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614216" class="sidefm-pmclink" style="text-transform: none;">Future Directions</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614349" class="sidefm-pmclink" style="text-transform: none;">References</a></div></span></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id549346">Abstract</div><div class="section-content"><!--article-meta-->We provide an overview of recent developments in carotid interventional technique and equipment, including new stents and emboli protection devices. The newer self-expanding stents lessen the problem of external stent compression associated with balloon expandable stents, but precise deployment and the matching (by length) of stents to lesions remain problematic. We also discuss emerging pharmacologic strategies for cerebral protection in stroke.<p>Multiple randomized clinical trials and multicenter registries are under way to compare percutaneous with surgical strategies for the treatment of carotid stenosis. These include the evaluation of emboli protection devices, and, to a lesser degree, intravenous glycoprotein IIb/IIIa antagonists. Other clinical trials are aimed towards refining the ability to stratify patients by risk, in order to identify the subsets that would benefit most from these complex and expensive procedures.</p><div class="p"><span class="kwd-label">Key words: </span><span class="kwd-text"><em>Angioplasty, balloon/adverse effects</em>; <em>blood vessel prosthesis implantation</em>; <em>brain ischemia/drug therapy/prevention &#x00026; control</em>; <em>carotid artery diseases/therapy</em>; <em>carotid stenosis</em>; <em>cerebrovascular disorders/prevention &#x00026; control</em>; <em>endarterectomy, carotid</em>; <em>prosthesis design</em>; <em>stents/utilization</em></span></div></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id549346" class="sidefm-pmclink" style="text-transform: none;">Abstract</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id658881" class="sidefm-pmclink" style="text-transform: none;">Equipment</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id613982" class="sidefm-pmclink" style="text-transform: none;">Pharmacology</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614094" class="sidefm-pmclink" style="text-transform: none;">Technique</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614160" class="sidefm-pmclink" style="text-transform: none;">Patient Selection and Risk Stratification</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614216" class="sidefm-pmclink" style="text-transform: none;">Future Directions</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614349" class="sidefm-pmclink" style="text-transform: none;">References</a></div></span></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id549402"> </div><div class="section-content"><p>Several randomized clinical trials (RCTs) have established the efficacy of endarterectomy for the prevention of stroke from carotid artery stenosis. <sup><a href="#r1-11" class="cite-reflink bibr">1,2</a></sup> The accumulated observational data and 1 randomized clinical trial suggest a comparable benefit-to-risk ratio with percutaneous methods. Ongoing basic and clinical trials are moving this field forward rapidly.</p><p>To keep things in perspective, it is critical to remember that the rapid pace of advances in drugs and devices constantly renders newly published data somewhat obsolete. Despite the incompleteness or unavailability of data for application to most clinical circumstances, we often cannot suspend making critical decisions or recommendations for the patient in front of us, and we must therefore rely on informed judgment, and on preliminary or indirect data.</p><p>There are many excellent published reviews on medical, percutaneous, and surgical approaches for carotid artery stenosis. <sup><a href="#r3-11" class="cite-reflink bibr">3&#x02013;7</a></sup> In this article, we therefore focus on providing the reader a glimpse of developments that are likely to have significant clinical impact in the coming months or years.</p></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id549346" class="sidefm-pmclink" style="text-transform: none;">Abstract</a></div></span><span style="text-transform: none;"></span><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);" style="text-transform: none;"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>Equipment</a></div><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id613982" class="sidefm-pmclink" style="text-transform: none;">Pharmacology</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614094" class="sidefm-pmclink" style="text-transform: none;">Technique</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614160" class="sidefm-pmclink" style="text-transform: none;">Patient Selection and Risk Stratification</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614216" class="sidefm-pmclink" style="text-transform: none;">Future Directions</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614349" class="sidefm-pmclink" style="text-transform: none;">References</a></div></span></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id658881">Equipment</div><div class="section-content"><p>The contemporary practice of carotid angioplasty and stenting (CAS) relies heavily on equipment and techniques developed for coronary artery percutaneous interventions. <sup><a href="#r8-11" class="cite-reflink bibr">8</a></sup> This is not an optimal situation from several standpoints. In particular, differences in anatomic conditions mandate different diagnostic and guide catheter designs.</p><p>For example, the current practice of seating the guide catheter tip into the common carotid artery (CCA) at a point approximately 1 cm below a typically located carotid bifurcation lesion requires that catheters access and negotiate the origin of the innominate or left common carotid arteries. This can be a problem when the aorta forms an acute angle with the innominate or left CCA. This elderly cohort of patients with carotid artery disease also tends to have tortuous, calcified arteries that are not pliant.</p><p>Second, there is a higher absolute plaque burden (in comparison with smaller arteries), and the current non-customized, bulky equipment can dislodge plaque all the way from the aortic arch to the lesion. The brain, of course, is a highly complex organ that is exquisitely sensitive to embolic events.</p><p>Third, currently available stents require delivery systems of relatively large caliber that compound the aforementioned problems. And fourth, aside from obstacles to acute technical success, long-term failures in the form of restenosis remain a problem. This section enumerates promising developments that target these issues.</p><p><em>Catheters</em>. Custom-shaped guide catheters are being developed to provide easier access to the origin of the cephalic vessels and to require less manipulation around the aortic arch. It is hoped that these can be tracked easily into the CCA, yet have adequate stiffness to be stable during passage of a stent from the arch into the innominate or left common carotid artery. Ultimately, an ideal catheter system should enable stent delivery with only minimal catheter-tip purchase beyond the aortic arch.</p><p><em>Stents</em>. Balloon-expandable stents were the standard for carotid artery stenting, but concerns about crushing due to external compression have shifted preference to self-expanding stents. <sup><a href="#r9-11" class="cite-reflink bibr">9,10</a></sup> Recent iterations of the latter are made with Nitinol, a biocompatible, equiatomic composite of nickel and titanium that has super-elastic properties at body temperature. This means that Nitinol self-expanding stents change crystal structure from Martensite back to Austenite in the human body, thereby recovering their originally engineered shape upon deployment. <sup><a href="#r11-11" class="cite-reflink bibr">11&#x02013;13</a></sup> Aside from crush recoverability, Nitinol-based stents offer dynamic scaffolding, and with certain designs, better wall apposition and conformability (<a href="articlerender.fcgi?artid=101079&amp;rendertype=figure&amp;id=f1-11" class="fig-table-link " onclick="startTarget(this, 'figure', 1024, 800)">Fig. 1</a>).</p><div style="margin: 1em; margin-right: 2em;        border: 1px solid #999999;border-left: 1px solid #AAAAAA;border-bottom: 1px solid #AAAAAA;"><div style="border: 3px solid #F0F0F0; border-left: 1px solid #F8F8F8; border-bottom: 1px solid #F8F8F8;"><a id="f1-11" name="f1-11"></a><table border="0" cellpadding="5" cellspacing="5" style="clear:both; width: 100%;"><tr valign="top" align="left"><td width="100" align="center"><a href="articlerender.fcgi?artid=101079&amp;rendertype=figure&amp;id=f1-11" class="icon-reflink" onclick="startTarget(this, 'figure', 1024, 800)"><img src="picrender.fcgi?artid=101079&amp;blobname=11FF1.gif" border="1" class="icon-reflink" alt="figure 11FF1" title="figure 11FF1"></a></td><td><a class="side-caption" href="articlerender.fcgi?artid=101079&amp;rendertype=figure&amp;id=f1-11" onclick="startTarget(this, 'figure', 1024, 800)"></a><div class="figure-table-caption-in-article"><span>Fig. 1 Comparison of Nitinol (<strong><em>A</em></strong>, <strong><em>B</em></strong>, <strong><em>C</em></strong>) with stainless steel stents (<strong><em>D</em></strong>), in regard to their conformability and wall apposition.</span></div></td></tr></table></div></div><div style="clear:both;"></div><p>Ongoing developments that focus on further miniaturization of equipment have enabled lower-profile stents and delivery systems (<a href="articlerender.fcgi?artid=101079&amp;rendertype=table&amp;id=t1-11" class="fig-table-link " onclick="startTarget(this, 'table', 1024, 800)">Table I</a>). Other experimental stent modifications may offer more favorable biological properties, including mitigation of thrombosis, attenuation of cellular activation and proliferation, and enhancement of endothelial-cell and vascular-wall function (<a href="articlerender.fcgi?artid=101079&amp;rendertype=table&amp;id=t2-11" class="fig-table-link " onclick="startTarget(this, 'table', 1024, 800)">Table II</a>).</p><div style="margin: 1em; margin-right: 2em;                                 border: 1px solid #999999;border-left: 1px solid #AAAAAA;border-bottom: 1px solid #AAAAAA;"><div style="border: 3px solid #F0F0F0; border-left: 1px solid #F8F8F8; border-bottom: 1px solid #F8F8F8;"><a id="t1-11" name="t1-11"></a><table border="0" cellpadding="5" cellspacing="5" style="clear:both; width: 100%;"><tr valign="top" align="left"><td width="100" align="center"><a href="articlerender.fcgi?artid=101079&amp;rendertype=table&amp;id=t1-11" class="icon-reflink" onclick="startTarget(this, 'table', 1024, 800)"><img src="corehtml/pmc/pmcgifs/table-icon.gif" border="1" class="icon-reflink" alt="Table thumbnail" title="Table thumbnail"></a></td><td><a class="side-caption" href="articlerender.fcgi?artid=101079&amp;rendertype=table&amp;id=t1-11" onclick="startTarget(this, 'figure', 1024, 800)"></a><div class="figure-table-caption-in-article"><span>Table I. Stent Profiles</span></div></td></tr></table></div></div><div style="clear:both;"></div><div style="margin: 1em; margin-right: 2em;                                 border: 1px solid #999999;border-left: 1px solid #AAAAAA;border-bottom: 1px solid #AAAAAA;"><div style="border: 3px solid #F0F0F0; border-left: 1px solid #F8F8F8; border-bottom: 1px solid #F8F8F8;"><a id="t2-11" name="t2-11"></a><table border="0" cellpadding="5" cellspacing="5" style="clear:both; width: 100%;"><tr valign="top" align="left"><td width="100" align="center"><a href="articlerender.fcgi?artid=101079&amp;rendertype=table&amp;id=t2-11" class="icon-reflink" onclick="startTarget(this, 'table', 1024, 800)"><img src="corehtml/pmc/pmcgifs/table-icon.gif" border="1" class="icon-reflink" alt="Table thumbnail" title="Table thumbnail"></a></td><td><a class="side-caption" href="articlerender.fcgi?artid=101079&amp;rendertype=table&amp;id=t2-11" onclick="startTarget(this, 'figure', 1024, 800)"></a><div class="figure-table-caption-in-article"><span>Table II. Experimental Stents</span></div></td></tr></table></div></div><div style="clear:both;"></div><p><em>Distal Emboli Protection Devices</em>. Plaque d&#x000e9;bris dislodged during CAS can cause irreversible cerebral infarctions. <sup><a href="#r14-11" class="cite-reflink bibr">14</a></sup> These have been documented in percutaneous interventions in different arterial beds; particles liberated during CAS have ranged in size from 16 micrometers to 6.2 millimeters. <sup><a href="#r15-11" class="cite-reflink bibr">15</a></sup></p><p>Emboli protection devices (EPDs) of several classes are currently undergoing clinical evaluation and should be a major breakthrough in making percutaneous vascular procedures safer. Filters and soft occlusive-balloon catheters are advanced past the lesion to prevent downstream escape of particles (<a href="articlerender.fcgi?artid=101079&amp;rendertype=figure&amp;id=f2-11" class="fig-table-link " onclick="startTarget(this, 'figure', 1024, 800)">Fig. 2</a>). Embolic d&#x000e9;bris is retrieved by collapsing the filter after CAS or by catheter aspiration prior to balloon deflation. <sup><a href="#r16-11" class="cite-reflink bibr">16</a></sup> Parodi is developing a circulatory control device system that creates temporary blood flow reversal from the carotid artery into a suctioning catheter positioned proximal to the carotid artery target lesion. <sup><a href="#r17-11" class="cite-reflink bibr">17</a></sup></p><div style="margin: 1em; margin-right: 2em;        border: 1px solid #999999;border-left: 1px solid #AAAAAA;border-bottom: 1px solid #AAAAAA;"><div style="border: 3px solid #F0F0F0; border-left: 1px solid #F8F8F8; border-bottom: 1px solid #F8F8F8;"><a id="f2-11" name="f2-11"></a><table border="0" cellpadding="5" cellspacing="5" style="clear:both; width: 100%;"><tr valign="top" align="left"><td width="100" align="center"><a href="articlerender.fcgi?artid=101079&amp;rendertype=figure&amp;id=f2-11" class="icon-reflink" onclick="startTarget(this, 'figure', 1024, 800)"><img src="picrender.fcgi?artid=101079&amp;blobname=11FF2.gif" border="1" class="icon-reflink" alt="figure 11FF2" title="figure 11FF2"></a></td><td><a class="side-caption" href="articlerender.fcgi?artid=101079&amp;rendertype=figure&amp;id=f2-11" onclick="startTarget(this, 'figure', 1024, 800)"></a><div class="figure-table-caption-in-article"><span>Fig. 2 Composite schematic of a filter-based emboli protection device</span></div></td></tr></table></div></div><div style="clear:both;"></div><p>There are important pitfalls to the current devices under investigation. None of these devices offers protection from embolic phenomena during the diagnostic catheterization phase, where up to 1&#x00025; of strokes occur. <sup><a href="#r1-11" class="cite-reflink bibr">1,18</a></sup> Also, to be positioned, these devices themselves must traverse the aortic arch and the proximal great vessels, which may likewise be diseased. <sup><a href="#r19-11" class="cite-reflink bibr">19</a></sup> Even when these devices are in place, the particle capture efficiency is far from perfect. <sup><a href="#r20-11" class="cite-reflink bibr">20</a></sup> Finally, the use of EPDs usually adds procedural time and complexity to a technique in which manipulation should be minimized. The potential advantages and disadvantages of each class of EPD are tabulated in <a href="articlerender.fcgi?artid=101079&amp;rendertype=table&amp;id=t3-11" class="fig-table-link " onclick="startTarget(this, 'table', 1024, 800)">Table III</a>.</p><div style="margin: 1em; margin-right: 2em;                                 border: 1px solid #999999;border-left: 1px solid #AAAAAA;border-bottom: 1px solid #AAAAAA;"><div style="border: 3px solid #F0F0F0; border-left: 1px solid #F8F8F8; border-bottom: 1px solid #F8F8F8;"><a id="t3-11" name="t3-11"></a><table border="0" cellpadding="5" cellspacing="5" style="clear:both; width: 100%;"><tr valign="top" align="left"><td width="100" align="center"><a href="articlerender.fcgi?artid=101079&amp;rendertype=table&amp;id=t3-11" class="icon-reflink" onclick="startTarget(this, 'table', 1024, 800)"><img src="corehtml/pmc/pmcgifs/table-icon.gif" border="1" class="icon-reflink" alt="Table thumbnail" title="Table thumbnail"></a></td><td><a class="side-caption" href="articlerender.fcgi?artid=101079&amp;rendertype=table&amp;id=t3-11" onclick="startTarget(this, 'figure', 1024, 800)"></a><div class="figure-table-caption-in-article"><span>Table III. Embolic Protection Devices: Potential Relative Advantages and Disadvantages</span></div></td></tr></table></div></div><div style="clear:both;"></div></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id549346" class="sidefm-pmclink" style="text-transform: none;">Abstract</a></div></span><span style="text-transform: none;"></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id658881" class="sidefm-pmclink" style="text-transform: none;">Equipment</a></div></span><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);" style="text-transform: none;"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>Pharmacology</a></div><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614094" class="sidefm-pmclink" style="text-transform: none;">Technique</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614160" class="sidefm-pmclink" style="text-transform: none;">Patient Selection and Risk Stratification</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614216" class="sidefm-pmclink" style="text-transform: none;">Future Directions</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614349" class="sidefm-pmclink" style="text-transform: none;">References</a></div></span></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id613982">Pharmacology</div><div class="section-content"><p>Randomized clinical trials in the coronary literature have established the central role of antiplatelet agents in decreasing peri- and post-procedural adverse events. Intravenous oral glycoprotein IIb/IIIa antagonists decrease 30-day thrombotic events by approximately 30&#x00025;. These results may not be amenable to extrapolation to CAS because large-vessel behavior may differ from that of coronary arteries, and the proportion of thrombus-based (versus plaque-based) emboli may be less in CAS (as indicated by material obtained from EPD studies). Furthermore, clinical observations have noted that peri-procedural stroke almost always occurs in the laboratory rather than at a later time. <sup><a href="#r21-11" class="cite-reflink bibr">21,22</a></sup> On the basis of a small consecutive series of 70 CAS patients who received adjunctive abciximab bolus and infusion, Kapadia has suggested that periprocedural events in high-risk patients might be mitigated without an increase in bleeding complications. <sup><a href="#r23-11" class="cite-reflink bibr">23</a></sup> Larger studies are needed to see if the benefits of this strategy outweigh the higher risks of intracerebral hemorrhage in this older population with a high prevalence of cerebrovascular comorbidities.</p><p>Similarly, the oral antiplatelet regimen for CAS is directly adapted from what is known from coronary stenting. <sup><a href="#r24-11" class="cite-reflink bibr">24,25</a></sup> Whether this dual coverage with aspirin and short-term clopidogrel or ticlopidine is optimal, or indeed overdone, with regard to drugs, dosing, and duration remains to be established. There is even evidence to suggest that oral antiplatelet drugs might, at early stages of carotid artery disease, attenuate the progression of carotid artery intima-media thickness.</p><p>A large potential exists for neuroprotective agents to play a role in the management of stroke patients, and possibly as adjunctive prophylaxis for the particulate emboli that are almost an inevitable consequence of CAS. When ischemia occurs, breakdown of ionic gradients results in membrane depolarization and an outpouring of excitatory amino acid neurotransmitters, particularly glutamate. Glutamate interacts with NMDA and non-NMDA receptors, which increases calcium conductance and raises intracellular calcium concentration. A series of cellular events results in activation of lipases, proteases, and nitric oxide synthetase, and in generation of nitric oxide and oxygen free radicals, which eventually leads to cellular death. Neuroprotective agents interfere with 1 or more steps in this ischemic cascade. Several neuroprotective agents target the NMDA receptors either by inhibition of glutamate binding or blockade of the glycine site, a cofactor in activation of these channels. Others interfere with the nitric oxide pathway (lubeluzole) or act through stabilization of membranes (citicoline). In animal models of stroke, neuroprotective agents have been effective when administered as long as 6 hours after onset of stroke, but are most effective when given immediately or within a few hours of onset. <sup><a href="#r26-11" class="cite-reflink bibr">26</a></sup> Several agents showed promise in phase II trials, <sup><a href="#r27-11" class="cite-reflink bibr">27&#x02013;30</a></sup> but to date all phase III randomized controlled trials of neuroprotective agents have failed to significantly improve outcome. <sup><a href="#r31-11" class="cite-reflink bibr">31&#x02013;34</a></sup></p><p>There are many potential reasons for the failure of these studies to demonstrate a significant clinical benefit, despite promising preclinical and phase II results. One of the reasons is the long interval before treatment, which in most cases was 6 hours or later. The use of neuroprotective agents in the setting of carotid stenting might provide an optimal application for this approach to treatment, because treatment can be given almost immediately after the onset of neurologic deficits or potentially can be given prophylactically and be on board when the stroke occurs. The preclinical studies suggest that this very early treatment might reduce neurologic deficits from stroke, even though such a benefit has not been demonstrated in randomized controlled trials of patients treated hours after the onset of stroke.</p></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id549346" class="sidefm-pmclink" style="text-transform: none;">Abstract</a></div></span><span style="text-transform: none;"></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id658881" class="sidefm-pmclink" style="text-transform: none;">Equipment</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id613982" class="sidefm-pmclink" style="text-transform: none;">Pharmacology</a></div></span><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);" style="text-transform: none;"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>Technique</a></div><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614160" class="sidefm-pmclink" style="text-transform: none;">Patient Selection and Risk Stratification</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614216" class="sidefm-pmclink" style="text-transform: none;">Future Directions</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614349" class="sidefm-pmclink" style="text-transform: none;">References</a></div></span></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id614094">Technique</div><div class="section-content"><p>Since minimal manipulation is a central principle for avoiding embolic complications, there are advocates of direct or primary stenting, which entails stenting without preceding balloon dilation. <sup><a href="#r35-11" class="cite-reflink bibr">35,36</a></sup> This strategy tests whether the avoidance of balloon predilation can improve procedural outcomes, and at the same time offer cost savings by skipping this step. A case series of carotid stenting, performed by European vascular surgeons, used this strategy with apparently acceptable 30-day outcomes. However, without vascular preparation with predilation, a relatively high profile stent may be expected to incur more vascular trauma, and indeed dissection (2&#x00025;) and vasospasm (1&#x00025;) were observed in this study. <sup><a href="#r37-11" class="cite-reflink bibr">37</a></sup> One RCT that routinely applied this technique was prematurely terminated because of unusually high event rates in the stent group, although the roles of final balloon sizing, other technical factors, learning curve, or simple chance are not clear. <sup><a href="#r38-11" class="cite-reflink bibr">38</a></sup> Whether there may be more or less embolic d&#x000e9;bris liberated using this approach needs to be cautiously studied now that lower-profile stents are available. Even then, this should start with the few patients who have carotid artery lesions with lumina that are unquestionably wider than the stent profile.</p><p>The concept of plaque trapping, sealing, and stabilization independent of relief of stenosis may eventually prove to be important. <sup><a href="#r8-11" class="cite-reflink bibr">8</a></sup> We have hypothesized that plaque stabilization is initially attained via coverage with the stent, with eventual quiescence of the lesion achieved by fibrosis. In the future, operators may become more tolerant of post-CAS residual stenosis, especially with the use of self-expanding stents, in exchange for safer acute outcomes.</p></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id549346" class="sidefm-pmclink" style="text-transform: none;">Abstract</a></div></span><span style="text-transform: none;"></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id658881" class="sidefm-pmclink" style="text-transform: none;">Equipment</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id613982" class="sidefm-pmclink" style="text-transform: none;">Pharmacology</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614094" class="sidefm-pmclink" style="text-transform: none;">Technique</a></div></span><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);" style="text-transform: none;"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>Patient Selection and Risk Stratification</a></div><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614216" class="sidefm-pmclink" style="text-transform: none;">Future Directions</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614349" class="sidefm-pmclink" style="text-transform: none;">References</a></div></span></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id614160">Patient Selection and Risk Stratification</div><div class="section-content"><p>Randomized clinical trials now under way will provide us valuable information regarding the appropriate role of CAS relative to carotid endarterectomy (CEA) or medical therapy (<a href="articlerender.fcgi?artid=101079&amp;rendertype=table&amp;id=t4-11" class="fig-table-link " onclick="startTarget(this, 'table', 1024, 800)">Table IV</a>). Just as important will be prospective registries that include the large majority of patients, who otherwise do not qualify for RCTs. These are the Carotid Revascularization with Stenting Systems (CARESS), which is a nonselective registry sponsored by the International Society of Endovascular Specialists (ISES), and the Acculink&#x02122; (Guidant) for Revascularization of Carotids in High Risk Patients (ARCHeR) study, which tracks the high-risk patients who were not eligible for CREST (Carotid Revascularization Endarterectomy versus Stenting Trial). Many different subanalyses will be performed to identify the patient subsets that derive the greatest benefit and the clinical parameters that predict high risk for procedure-related complications. Rothwell has shown that most of the long-term benefits from carotid endarterectomy (CEA) are clustered in only a fifth of the patients in the European Carotid Surgery Trial (ECST), i.e., in those with 70&#x00025; to 99&#x00025; stenosis. <sup><a href="#r39-11" class="cite-reflink bibr">39</a></sup> This implies that up to 80&#x00025; of patients subjected to the perioperative risks of CEA did not derive a net benefit. Refinement of our knowledge of prognostic factors will be critical in assisting both clinicians and patients to ascertain individualized benefit-to-risk ratios, and will help determine the most beneficial strategy (medical therapy, CAS, or CEA) for each patient. A prospectively validated model for stratifying patients according to risk of periprocedural death or stroke is already available for CEA. <sup><a href="#r40-11" class="cite-reflink bibr">40</a></sup> Once large data-sets are available from both registries and randomized clinical trials, prediction models can be constructed to identify those patients at high risk for complications with either CEA or CAS, leading to appropriate consideration of the alternative treatment.</p><div style="margin: 1em; margin-right: 2em;                                 border: 1px solid #999999;border-left: 1px solid #AAAAAA;border-bottom: 1px solid #AAAAAA;"><div style="border: 3px solid #F0F0F0; border-left: 1px solid #F8F8F8; border-bottom: 1px solid #F8F8F8;"><a id="t4-11" name="t4-11"></a><table border="0" cellpadding="5" cellspacing="5" style="clear:both; width: 100%;"><tr valign="top" align="left"><td width="100" align="center"><a href="articlerender.fcgi?artid=101079&amp;rendertype=table&amp;id=t4-11" class="icon-reflink" onclick="startTarget(this, 'table', 1024, 800)"><img src="corehtml/pmc/pmcgifs/table-icon.gif" border="1" class="icon-reflink" alt="Table thumbnail" title="Table thumbnail"></a></td><td><a class="side-caption" href="articlerender.fcgi?artid=101079&amp;rendertype=table&amp;id=t4-11" onclick="startTarget(this, 'figure', 1024, 800)"></a><div class="figure-table-caption-in-article"><span>Table IV. Randomized Clinical Trials Comparing Carotid Angioplasty and Stenting to Carotid Endarterectomy</span></div></td></tr></table></div></div><div style="clear:both;"></div></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id549346" class="sidefm-pmclink" style="text-transform: none;">Abstract</a></div></span><span style="text-transform: none;"></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id658881" class="sidefm-pmclink" style="text-transform: none;">Equipment</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id613982" class="sidefm-pmclink" style="text-transform: none;">Pharmacology</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614094" class="sidefm-pmclink" style="text-transform: none;">Technique</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614160" class="sidefm-pmclink" style="text-transform: none;">Patient Selection and Risk Stratification</a></div></span><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);" style="text-transform: none;"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>Future Directions</a></div><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614349" class="sidefm-pmclink" style="text-transform: none;">References</a></div></span></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id614216">Future Directions</div><div class="section-content"><p>The availability of the genetic sequences for man (the Human Genome Project) and for key model organisms such as <em>Escherichia coli</em>, the zebra fish (<em>Danio rerio</em>), the fruit fly (<em>Drosophila melanogaster</em>), and the mouse (<em>Mus musculus</em>) will stimulate the development of new paradigms for the prevention, diagnosis, and treatment of human diseases. <sup><a href="#r41-11" class="cite-reflink bibr">41</a></sup> Early identification of people at high risk for atherosclerotic disease may help target efforts at prevention. For instance, there is evidence that suggests a higher prevalence of severe carotid disease among patients with renovascular hypertension who carry the DD genotype of the angiotensin-converting enzyme (ACE) gene. <sup><a href="#r42-11" class="cite-reflink bibr">42</a></sup> For arterial restenosis, studies have focused on polymorphisms of genes encoding for proteins that interfere with lipid metabolism, hemostasis, nitric oxide production, inflammatory mechanisms, smooth-muscle-cell proliferation, and matrix production. <sup><a href="#r43-11" class="cite-reflink bibr">43&#x02013;46</a></sup> Genes encoding for angiotensin-converting enzyme, platelet glycoprotein-IIIa, transforming growth factor &#x003b2; (TGF-&#x003b2;), and stromelysin-1 are genetic candidates suspected to play a role in restenosis. <sup><a href="#r47-11" class="cite-reflink bibr">47&#x02013;53</a></sup> Despite recent setbacks in human trials, proof of principle has been achieved for gene therapy in the abrogation of smooth-muscle-cell growth in the rat model for carotid artery balloon injury, which foreshadows the immense promise of this field. <sup><a href="#r54-11" class="cite-reflink bibr">54&#x02013;57</a></sup></p><p>Ultimately, prevention is always the best approach. Initiatives to educate patients and their families about the crucial role of proper diet, exercise, and abstinence from smoking remain a priority, not only for public health agencies but for the individual health-care practitioner. Technological development of less invasive testing methods will also play an increasing role in health care. For instance, noninvasive indicators of early carotid artery atherosclerosis, such as the evaluation of intima-media thickness by B-mode ultrasound, have been associated with an elevated risk for future ischemic stroke. <sup><a href="#r58-11" class="cite-reflink bibr">58</a></sup> This finding also serves as a correlate of atherosclerosis in other vascular trees. <sup><a href="#r59-11" class="cite-reflink bibr">59</a></sup> Indeed, the major cause of death in patients with carotid artery stenosis is myocardial infarction and heart failure, and intima-media thickness has been shown to be predictive of cardiovascular events as well. <sup><a href="#r60-11" class="cite-reflink bibr">60</a></sup> Our approach to carotid artery stenosis and stroke will someday be only a component of a global approach to atherosclerotic disease, in our efforts to offer our patients a comprehensive perspective on preserving their health and longevity.</p></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"> </td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="footnotes">Footnotes</div><div class="section-content"><div class="fm-footnote"><div class="p"><strong><em>Address for reprints:</em></strong> Walter A. Tan, MS, MD, Pittsburgh Vascular Institute, UPMC Shadyside, 5230 Centre Avenue, Pittsburgh, PA 15232</div><p>Presented at the Texas Heart&#x000ae; Institute's symposium on Peripheral Interventions for the Cardiovascular Specialist, held on 4-5 November 1999, at the Marriott Medical Center Hotel, Houston, Texas</p></div></div></td></tr><tr valign="top"><td class="sidebar-cell" width="145"><div class="side-section-group"><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#top" class="sidefm-pmclink" style="text-transform: none;">Top</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id549346" class="sidefm-pmclink" style="text-transform: none;">Abstract</a></div></span><span style="text-transform: none;"></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id658881" class="sidefm-pmclink" style="text-transform: none;">Equipment</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id613982" class="sidefm-pmclink" style="text-transform: none;">Pharmacology</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614094" class="sidefm-pmclink" style="text-transform: none;">Technique</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614160" class="sidefm-pmclink" style="text-transform: none;">Patient Selection and Risk Stratification</a></div></span><span style="text-transform: none;"><div class="sidefm-pmclink-item"><a href="#id614216" class="sidefm-pmclink" style="text-transform: none;">Future Directions</a></div></span><div class="sidefm-pmccurrent-item"><a class="sidefm-pmclink" href="javascript:return(false);" style="text-transform: none;"><span class="sidebar-menu-square-image-holder"><img border="0" src="corehtml/pmc/pmcgifs/square.gif" alt="&gt;"></span>References</a></div></div></td><td class="content-cell"><div class="head1 section-title" style="text-transform: none;" id="id614349">References</div><div class="section-content"><div class="back-matter-section"><div class="ref-cit-blk" id="r1-11"><div class="ref-label">1.</div><div class="ref-cit">Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators [see comments]. N Engl J Med 1991;325:445&#x02013;53.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0n_oWkLP2Zy_lhSl6zP7oHase5EKMliU1Iut0Uk_Q&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/1852179">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r2-11"><div class="ref-label">2.</div><div class="ref-cit">Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial [see comments]. Lancet 1998;351: 1379&#x02013;87.</div></div><div class="ref-cit-blk" id="r3-11"><div class="ref-label">3.</div><div class="ref-cit">Barnett HJ, Eliasziw M, Meldrum HE. Evidence based cardiology: Prevention of ischaemic stroke. BMJ 1999;318: 1539&#x02013;43.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0ZA-f9VKcGUjqSaWJEY5xgJx5yGRKXCl6Kv2JfAAP&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10356014">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r4-11"><div class="ref-label">4.</div><div class="ref-cit">Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators [see comments]. N Engl J Med 1998;339:1415&#x02013;25.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0LOj5IIhgH74jJM_35o19uYfe9IzE30GwIg58i53y&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9811916">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r5-11"><div class="ref-label">5.</div><div class="ref-cit">Roubin GS, Yadav S, Iyer SS, Vitek J. Carotid stent-supported angioplasty: a neurovascular intervention to prevent stroke. Am J Cardiol 1996;78(3A):8&#x02013;12.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0DEIgZavnxL4-SZHYtqwUrCF-KQlkxRJJrmKXzAo3&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8751840">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r6-11"><div class="ref-label">6.</div><div class="ref-cit">Wholey MH, Jarmolowski CR, Eles G, Levy D, Buecthel J. Endovascular stents for carotid artery occlusive disease. J Endovasc Surg 1997;4:326&#x02013;38.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=08qhE6Y1omfsvMo3OkW3pWahrNBaaGnwdSZnWUkJX&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9418194">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r7-11"><div class="ref-label">7.</div><div class="ref-cit">Henry M, Amor M, Masson I, Henry I, Tzvetanov K, Chati Z, et al. Angioplasty and stenting of the extracranial carotid arteries. J Endovasc Surg 1998;5:293&#x02013;304.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0PWCNXaTYxaJ68l_xwyf_nMpbIWBxuA4_ZpX8xk3i&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9867317">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r8-11"><div class="ref-label">8.</div><div class="ref-cit">Tan WA, Wholey MH, Jarmolowski CR, Eles G, Wholey MH. Carotid angioplasty and stenting: current benchmarks and future goals. In: Veith FJ, Amor M, editors. Current status of carotid bifurcation angioplasty and stenting. New York: Marcel Dekker, Inc., 2000. In press.</div></div><div class="ref-cit-blk" id="r9-11"><div class="ref-label">9.</div><div class="ref-cit">Mathur A, Dorros G, Iyer SS, Vitek JJ, Yadav SS, Roubin GS. Palmaz stent compression in patients following carotid artery stenting. Cathet Cardiovasc Diagn 1997;41:137&#x02013;40.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0HWSYDLgpm1uzS54BlJwT2w3nq2wyB38IlEb5QQRb&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9184284">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r10-11"><div class="ref-label">10.</div><div class="ref-cit">Wholey MH, Wholey M, Bergeron P, Diethrich EB, Henry M, Laborde JC, et al. Current global status of carot-id artery stent placement [see comments]. Cathet Cardiovasc Diagn 1998;44:1&#x02013;6.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0zIdag4QSee6UHmRbjn5LxLd7zBIyaQcnnCTS65NF&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9600512">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r11-11"><div class="ref-label">11.</div><div class="ref-cit">Ryhanen J, Niemi E, Serlo W, Niemela E, Sandvik P, Pernu H, et al. Biocompatibility of nickel-titanium shape memory metal and its corrosion behavior in human cell cultures. J Biomed Mater Res 1997;35:451&#x02013;7.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=06gedipirZhEe9JiQqIJ8VW3TD2AKmv-mI-Cmy5xg&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9189823">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r12-11"><div class="ref-label">12.</div><div class="ref-cit">Ryhanen J, Kallioinen M, Tuukkanen J, Junila J, Niemela E, Sandvik P, et al. In vivo biocompatibility evaluation of nickel-titanium shape memory metal alloy: muscle and perineural tissue responses and encapsule membrane thickness. J Biomed Mater Res 1998;41:481&#x02013;8.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0JeliWCD8GY3pkp4vMlCFeln1Nyd6hcUGKlwesA2_&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9659619">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r13-11"><div class="ref-label">13.</div><div class="ref-cit">Verheye S, Salame MY, Robinson KA, Post MJ, Carrozza JP Jr, Baim DS, et al. Short- and long-term histopathologic evaluation of stenting using a self-expanding nitinol stent in pig carotid and iliac arteries. Catheter Cardiovasc Interv 1999;48:316&#x02013;23.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=02qs_haPObR_69mcLaBstr5x92i2ddQJxioscsAws&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10525238">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r14-11"><div class="ref-label">14.</div><div class="ref-cit">Theron J, Courtheoux P, Alachkar F, Bouvard G, Maiza D. New triple coaxial catheter system for carotid angioplasty with cerebral protection. AJNR Am J Neuroradiol 1990; 11:869&#x02013;77.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0hERW6fMOEN531fdbU2C3J3w1u-D7w_LY-TZst549&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/2145730">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r15-11"><div class="ref-label">15.</div><div class="ref-cit">Henry M, Amor M, Henry I, Klonaris C, Masson I, Le-borgne E. Protected carotid angioplasty and stenting with the PercuSurge Guardwire. J Vasc Interv Radiol 2000; 11(Suppl):216.</div></div><div class="ref-cit-blk" id="r16-11"><div class="ref-label">16.</div><div class="ref-cit">Whitlow PL, Lylyk P, Londero H, Parodi J, Schonholz C. Protected carotid stenting with the PercuSurge Guardwire: results from a multi specialty study group. J Am Coll Cardiol 2000;35:85A.</div></div><div class="ref-cit-blk" id="r17-11"><div class="ref-label">17.</div><div class="ref-cit">Parodi JC. Initial evaluation of carotid angioplasty and stenting using 3 different cerebral protection devices. J Endovasc Ther 2000;7(Suppl I):1&#x02013;30.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0l_emGDQ8FntCstwJ0VNxkhcSuUVLhb8fHEdw_Q6C&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10772742">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r18-11"><div class="ref-label">18.</div><div class="ref-cit">Davies KN, Humphrey PR. Complications of cerebral angiography in patients with symptomatic carotid territory ischaemia screened by carotid ultrasound. J Neurol Neurosurg Psychiatry 1993;56:967&#x02013;72.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0jKT1au9jz_IUFLCAcedcE9NCNxE9qtvsc4LzxQeb&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8410036">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r19-11"><div class="ref-label">19.</div><div class="ref-cit">Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke [see comments]. N Engl J Med 1994;331:1474&#x02013;9.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0z16yLFyz4oUYWkdd8MQXPpvxX51w6p6baUwT_QKG&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/7969297">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r20-11"><div class="ref-label">20.</div><div class="ref-cit">Ohki T, Roubin GS, Veith FJ, Iyer SS, Brady E. Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting: An ex vivo analysis. J Vasc Surg 1999;30:1034&#x02013;44.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0Z7OTffhyzjOpBHFP-shb9AuK4aUiqycukImDQAci&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10587387">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r21-11"><div class="ref-label">21.</div><div class="ref-cit">Ohki T, Marin ML, Lyon RT, Berdejo GL, Soundararajan K, Ohki M, et al. Ex vivo human carotid artery bifurcation stenting: correlation of lesion characteristics with embolic potential. J Vasc Surg 1998;27:463&#x02013;71.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0bWxBQDEEE_VFK-jUHeQ2jU7mHjTCJiP8_JtKAAli&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9546231">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r22-11"><div class="ref-label">22.</div><div class="ref-cit">Tan WA, Jarmolowski CR, Eles G, et al. Lack of protection despite adjunctive intravenous platelet glycoprotein IIb/IIIa inhibition in carotid artery stenting (PCA). Unpublished Data.</div></div><div class="ref-cit-blk" id="r23-11"><div class="ref-label">23.</div><div class="ref-cit">Kapadia SR, Bajzer CT, Ziada KM, Silver MJ, Cura FA, L'Allier PL, et al. Initial experience of glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe adjunctive therapy. J Am Coll Cardiol 2000;35:86A.</div></div><div class="ref-cit-blk" id="r24-11"><div class="ref-label">24.</div><div class="ref-cit">Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents [see comments]. N Engl J Med 1996; 334:1084&#x02013;9.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0V5sTSBlO3k74U6YdKodIZnFLnCxDgNDLEcOvAkd3&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8598866">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r25-11"><div class="ref-label">25.</div><div class="ref-cit">Muller C, Buttner HJ, Petersen J, Roskamm H. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 2000;101:590&#x02013;3.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=00elXxB6G6jg4oC8lGTXKpnP49Igp5vHO3qvLTQIe&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10673248">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r26-11"><div class="ref-label">26.</div><div class="ref-cit">Grotta JC. Acute stroke therapy at the millennium: consummating the marriage between the laboratory and bedside. The Feinberg lecture. Stroke 1999;30:1722&#x02013;8.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0hQBz5Mv0QpfqHqtrUAS2TIAkn9JZHVSOsB2uz5c1&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10436128">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r27-11"><div class="ref-label">27.</div><div class="ref-cit">Diener HC, Hacke W, Hennerici M, Radberg J, Hantson L, De Keyser J. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group. Stroke 1996;27:76&#x02013;81.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0tu57J05EIOPZr06hVn7WcwYrmp6ZsfWn1Q39AQEZ&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8553408">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r28-11"><div class="ref-label">28.</div><div class="ref-cit">Davis SM, Albers GW, Diener HC, Lees KR, Norris J. Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committee. Lancet 1997;349:32.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=04cw9CgliNIiMDHGTJ-L9VWoH_h1YKfc3zt_VZkCB&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8999265">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r29-11"><div class="ref-label">29.</div><div class="ref-cit">Grotta J, Clark W, Coull B, Pettigrew LC, Mackay B, Goldstein LB, et al. Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. Stroke 1995;26:602&#x02013;5.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0VCfrbhwRBgxPSqqxVg9crqiPXyiVWGRYl1djzAs-&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/7709405">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r30-11"><div class="ref-label">30.</div><div class="ref-cit">Albers GW, Atkinson RP, Kelley RE, Rosenbaum DM. Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group. Stroke 1995;26:254&#x02013;8.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0lOV1ut-G_wtMObktfg7E1RuuJMF3xVD7wzwx8QD_&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/7831698">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r31-11"><div class="ref-label">31.</div><div class="ref-cit">Davis SM, Lees KR, Albers GW, Diener HC, Markabi S, Karlsson G, et al. Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke 2000; 31:347&#x02013;54.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0jc_m2ySjcNbZUxtv2_jmqRfilK12NRRAtV2u45FZ&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10657404">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r32-11"><div class="ref-label">32.</div><div class="ref-cit">Diener HC. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. European and Australian Lubeluzole Ischaemic Stroke Study Group. Cerebrovasc Dis 1998;8:172&#x02013;81.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=08koC0Kd3zApCmnXt4zKfNjHWwJXkzHP1pBsjkkrq&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9619701">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r33-11"><div class="ref-label">33.</div><div class="ref-cit">Grotta J. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group [see comments]. Stroke 1997;28:2338&#x02013;46.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0vIy6MXYmRWxMGxJpA5eUgbwdNMQoSX7ismjackMO&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9412611">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r34-11"><div class="ref-label">34.</div><div class="ref-cit">Clark WM, Williams BJ, Selzer KA, Zweifler RM, Sa-bounjian LA, Gammans RE. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke 1999;30:2592&#x02013;7.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=069BfL_Opc18XyFDlwSM25Qf6Bt1rBX2vt7OVM5pf&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10582983">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r35-11"><div class="ref-label">35.</div><div class="ref-cit">Mathias K. Catheter treatment of arterial occlusive disease of supra-aortic vessels [in German]. Radiology 1987;27:547&#x02013;54.</div></div><div class="ref-cit-blk" id="r36-11"><div class="ref-label">36.</div><div class="ref-cit">Bruger C, Sheiban I, De Gregorio J, Anzuini A, Montorfano M, Pagnotta P, et al. Direct coronary stenting without predilation. J Am Coll Cardiol 1999;34:1910&#x02013;5.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=08_q2gOTHwuNM5AIdhxDMJYZFQgD-jK7hTaamyQiq&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10588203">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r37-11"><div class="ref-label">37.</div><div class="ref-cit">Bergeron P, Becquemin JP, Jausseran JM, Biasi G, Cardon JM, Castellani L, et al. Percutaneous stenting of the internal carotid artery: the European CAST I Study. Carotid Artery Stent Trial. J Endovasc Surg 1999;6:155&#x02013;9.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0vUNMT3ARYCPi0j4A3lnvNCcf_VeCeCeLXIGn3QBD&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10473333">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r38-11"><div class="ref-label">38.</div><div class="ref-cit">Naylor AR, Bolia A, Abbott RJ, Pye IF, Smith J, Lennard N, et al. Randomized study of carotid angioplasty and stenting versus carotid endart e rectomy: a stopped trial. J Vasc Surg 1998;28:326&#x02013;34.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=02WrgUgUOVY5DL9Bv4JaqZNDr1TKlf3PAJSI57QzU&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9719328">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r39-11"><div class="ref-label">39.</div><div class="ref-cit">Rothwell PM, Warlow CP. Prediction of benef it from carotid endarterectomy in individual patients: a risk-mod-elling study. European Carotid Surgery Trialists' Collabo-rative Group. Lancet 1999;353:2105&#x02013;10.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0F52CDXzICDjFbk-E6YQ5uFTLtAZXwjtWNjk_6QcK&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10382694">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r40-11"><div class="ref-label">40.</div><div class="ref-cit">Rothwell PM, Slattery J, Warlow CP. Clinical and angiog-raphic predictors of stroke and death from carotid endarterectomy: systematic review [see comments]. BMJ 1997; 315:1571&#x02013;7.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0-cTrltZx0ITVStL6iH2nVtzckiwR57yftkE2r5K0&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9437274">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r41-11"><div class="ref-label">41.</div><div class="ref-cit">National Human Genome Research Institute. Available at <span class="ext-reflink"><a href="redirect3.cgi?&amp;&amp;auth=0tS4aPigSduYmzv0beHH4JeoY0pe-bNQJ5_7yw5dh&amp;reftype=extlink&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal&amp;&amp;http://www.nhgri.nih.gov" class="ext-reflink" target="pmc_ext" onclick="focuswin('pmc_ext')">http://www.nhgri.nih.gov</a></span>.</div></div><div class="ref-cit-blk" id="r42-11"><div class="ref-label">42.</div><div class="ref-cit">Losito A, Selvi A, Jeffery S, Afzal AR, Parente B, Cao PG. Angiotensin-converting enzymegene I/D polymorphism and carotidartery disease in renovascular hypertension. Am J Hypertens 2000;13:128&#x02013;33.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0tscuHMdSosGaatDHlMp7en9OfxwqT1oFXmjTBkQ0&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10701811">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r43-11"><div class="ref-label">43.</div><div class="ref-cit">Plow EF, Ploplis VA, Busuttil S, Carmeliet P, Collen D. A role of plasminogen in athero sclerosis and restenosis models in mice. Thromb Haemost 1999;82(Suppl 1):4&#x02013;7.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0rS-jBojCLzOad6X98C_bh1ridgXl1voIp7pRmATz&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10695477">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r44-11"><div class="ref-label">44.</div><div class="ref-cit">Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblas-toma gene product. Science 1995;267:518&#x02013;22.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0Xo9dgrY3aizjD_1nLihsAu5kPa1bTFtW_b9jmkH9&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/7824950">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r45-11"><div class="ref-label">45.</div><div class="ref-cit">Schneider DB, Vassalli G, Wen S, Driscoll RM, Sassani AB, De Young MB, et al. Expression of Fasligand in arteries of hypercholeste rolemic rabbits accelerates athero sclerotic lesion formation. Arterioscler Thromb Vasc Biol 2000;20:298&#x02013;308.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0jCnMgI1jShLRjQzMgmBq_kvEdH9gtSsBJAYxkQaf&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10669624">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r46-11"><div class="ref-label">46.</div><div class="ref-cit">Bayes-Genis A, Conover CA, Schwartz RS. The insulin-like growth factor axis: A review of athero sclerosis and restenosis. Circ Res 2000;86:125&#x02013;30.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0FcN2PPPzGJ3b9GPnNTKMvgLL4x3oSEATbg7uhQ8D&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10666406">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r47-11"><div class="ref-label">47.</div><div class="ref-cit">Chandrasekar B, Tanguay JF. Platelets and restenosis. J Am Coll Cardiol 2000;35:555&#x02013;62.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0bWZfXDL4Oe_FI-hzYwChk717ZKreuqjrPVtd6A0e&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10716455">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r48-11"><div class="ref-label">48.</div><div class="ref-cit">Bauters C, Amouyel P, Bertrand ME. ACE gene polymorphism and coronary restenosis. Semin Interv Cardiol 1999; 4:145&#x02013;9.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0Hu8ScoymFSANVusE50zwyWhYZoXwEKcAyUQpEQmU&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10545620">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r49-11"><div class="ref-label">49.</div><div class="ref-cit">Ohishi M, Fujii K, Minamino T, Higaki J, Kamitani A, Rakugi H, et al. A potent genetic risk factor for restenosis [letter]. Nat Genet 1993;5:324&#x02013;5.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0lgusNdd9WJjn36Knv6n-mQ0CJxhNo-0w9QiRN5l8&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8298638">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r50-11"><div class="ref-label">50.</div><div class="ref-cit">Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 1994;93:339&#x02013;46.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=08idVnFIZV1BcMGFAyIN9S6jmRnj_rsRYZqZI0QqP&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8282805">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r51-11"><div class="ref-label">51.</div><div class="ref-cit">Dzau VJ. Cell biology and genetics of angiotensin in cardiovascular disease. J Hypertens Suppl 1994;12:S3&#x02013;10.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0dAFgPbnZ0fJruvEACcLUjhmQM6KNaImn7oWbYA_i&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/7965271">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r52-11"><div class="ref-label">52.</div><div class="ref-cit">Kastrati A, Dirschinger J, Schomig A. Genetic risk factors and restenosis after percutaneous coronary interventions. Herz 2000;25:34&#x02013;46.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0le_dRjy0gcWZOUpxj8Dep7FUKrbcOOmzQ7QFPAEK&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10713908">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r53-11"><div class="ref-label">53.</div><div class="ref-cit">Mamotte CD, van Bockxmeer FM, Taylor RR. PIa 1 / a 2 polymorphism of glyc o p rotein IIIa and risk of coro n a r y results from a multi specialty study group. J Am Coll Car-diol 2000;35:85A.</div></div><div class="ref-cit-blk" id="r54-11"><div class="ref-label">54.</div><div class="ref-cit">Chang MW, Ohno T, Gordon D, Lu MM, Nabel GJ, Nabel EG, et al. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery. Mol Med 1995;1:172&#x02013;81.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0nskvazN0_qlbjTf9rCawZ3bleqKOjuhtDfXRokac&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8529096">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r55-11"><div class="ref-label">55.</div><div class="ref-cit">De Young MB, Dichek DA. Gene therapy for restenosis: are we ready? [see comments]. Circ Res 1998;82:306&#x02013;13.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0Rk_K2J9-ANh11OuCm1YJa1eFP74CbYaIE2G50556&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9486658">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r56-11"><div class="ref-label">56.</div><div class="ref-cit">Rade JJ, Schulick AH, Virmani R, Dichek DA. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nat Med 1996;2:293&#x02013;8.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0HO65WgaeumQbxcWFFi1BjimUUHBnFfT8Pf1lH54A&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8612227">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r57-11"><div class="ref-label">57.</div><div class="ref-cit">Vassalli G, Dichek DA. Gene therapy for arterial thrombosis. Cardiovasc Res 1997;35:459&#x02013;69.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0riziljwLngr1gUKEabFHDR-9SswWSneNfP0U7QEY&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9415290">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r58-11"><div class="ref-label">58.</div><div class="ref-cit">Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ, et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000;151:478&#x02013;87.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=02cqc-K_KnIqVMf5ZCyIffXSL5vaOZLywjcjoKADy&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10707916">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r59-11"><div class="ref-label">59.</div><div class="ref-cit">Saito D, Shiraki T, Oka T, Kajiyama A, Doi M, Masaka T. Morphologic correlation between atherosclerotic lesions of the carotid and coronary arteries in patients with angina pectoris. Jpn Circ J 1999;63:522&#x02013;6.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0Fg7WovPjXCNRGE63FYf6Bcs33Ef5H4aEuLLfqAmp&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10462018">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r60-11"><div class="ref-label">60.</div><div class="ref-cit">Paciaroni M, Eliasziw M, Kappelle LJ, Finan JW, Ferguson GG, Barnett HJ. Medical complications associated with carotid endarterectomy. North American Symptomatic Carotid Endarterectomy Trial [see comments]. St roke 1999;30:1759&#x02013;63.</div></div><div class="ref-cit-blk" id="r61-11"><div class="ref-label">61.</div><div class="ref-cit">Conte MS, Birinyi LK, Miyata T, Fallon JT, Gold HK, Whittemore AD, et al. Efficient repopulation of denuded rabbit arteries with autologous genetically modified endothelial cells. Circulation 1994;89:2161&#x02013;9.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0BUSItfya3g3BOhgqBW7XG8ZvF3wQlnI53jCiIA3l&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8181141">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r62-11"><div class="ref-label">62.</div><div class="ref-cit">Flugelman MY, Virmani R, Leon MB, Bowman RL, Dichek DA. Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro. Circ Res 1992;70:348&#x02013;54.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0NGkkcon_eniqTyvPmg5RwBxrnS7DWS8hvpCmU5rB&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/1735134">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r63-11"><div class="ref-label">63.</div><div class="ref-cit">Fischell TA, Hehrlein C, Fischell RE, Fischell DR. The impact of stent design and delivery upon the long-term efficacy of radioisotope stents. J Invasive Cardiol 2000;12:162&#x02013;7.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0L79BptziYLD4hWFLYVMrO4Zc4NPKJPzT5gOjiAde&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10731287">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r64-11"><div class="ref-label">64.</div><div class="ref-cit">Hardhammar PA, van Beusekom HM, Emanuelsson HU, Hofma SH, Albertsson PA, Verdouw PD, et al. Reduction in thrombotic events with heparin-coated Palmaz-Schatzstents in normal porcine coronary arteries. Circulation 1996;93:423&#x02013;30.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=06QYAGEc9d7zWnwEbpbCBXkr_QB8NKKJRA82pwAMM&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8565158">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r65-11"><div class="ref-label">65.</div><div class="ref-cit">Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease [published erratum appears in Lancet 1998;31;352:1478]. Lancet 1998; 352:673&#x02013;81.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0L7Fcjics92qYHBTuFFmvkwalTtnnXVi0ZGPl359b&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9728982">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r66-11"><div class="ref-label">66.</div><div class="ref-cit">de Scheerder I, Wang K, Wilczek K, van Dorpe J, Verbeken E, Desmet W, et al. Local methylprednisolone inhibition of foreign body response to coated intracoronary stents. Coron Artery Dis 1996;7:161&#x02013;6.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=02a1iF2Ope6h2krZwY-vIu8g6fTKoOdygf0golkUU&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8813449">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r67-11"><div class="ref-label">67.</div><div class="ref-cit">Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery [see comments]. Circulation 1997;96:636&#x02013;45.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0LgwqaCLUCRdKH3RbNgFB76lfOB5s1asQbdC4YkAJ&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9244237">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r68-11"><div class="ref-label">68.</div><div class="ref-cit">De Scheerder I, Wilczek K, Van Dorpe J, Verbeken E, Cathapermal S, Wang K, et al. Local angiopeptin delivery using coated stents reduces neointimal proliferation in overstretched porcine coronary arteries. J Invasive Cardiol 1996;8:215&#x02013;222.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=00U_wMWx0tDeEnxA-QZO8mnggV1qvhkpShfRTmkZe&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/10785709">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r69-11"><div class="ref-label">69.</div><div class="ref-cit">Alberts MJ, McCann R, Smith TP. A randomized trial of carotid stenting vs. endarterectomy in patients with symptomatic carotid stenosis: study design. J Neurovascular Dis 1997;2:228&#x02013;234.</div></div><div class="ref-cit-blk" id="r70-11"><div class="ref-label">70.</div><div class="ref-cit">Sivaguru A, Venables GS, Beard JD, Gaines PA. European carotid angioplasty trial [see comments]. J Endovasc Surg 1996;3:16&#x02013;20.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0RMslaZkdREVNl5zzRTthbLxBKUTio6-BU1mZAkMI&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/8798121">PubMed</a>]</span>.</div></div><div class="ref-cit-blk" id="r71-11"><div class="ref-label">71.</div><div class="ref-cit">Hobson RW, 2nd, Brott T, Ferguson R, Roubin G, Moore W, Kuntz R, et al. CREST: carotid revascularization endarterectomy versus stent trial [editorial]. Cardiovasc Surg 1997;5:457&#x02013;8.  <span style="white-space: nowrap;">[<a class="ref-extlink" href="redirect3.cgi?&amp;&amp;auth=0XqmrTsXzMj9IRpRI51sKWcKCvmmzrsJB4pC3h5Hv&amp;reftype=pubmed&amp;artid=101079&amp;article-id=101079&amp;iid=2762&amp;issue-id=2762&amp;jid=92&amp;journal-id=92&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal&amp;&amp;http://www.ncbi.nlm.nih.gov/pubmed/9464598">PubMed</a>]</span>.</div></div></div></div></td></tr><tr><td></td><td class="content-cell"><div class="footer-section"><hr><div class="sans90" style="margin: 0em 1em 1em; text-align: center;">Articles from <span class="acknowledgment-journal-title">Texas Heart Institute Journal</span> are provided here courtesy of <br><b>Texas Heart Institute</b></div>
      <div class="footer-link" id="fp-footer">
        <div>
          <a class="link" href="mailto:pubmedcentral@nih.gov">Write to PMC</a>
           | 
          <a class="link" href="./">PMC Home</a>
           | 
          <a class="link" href="http://www.ncbi.nlm.nih.gov/pubmed">PubMed</a>
        </div>
        <div>
          <a class="link" href="http://www.ncbi.nlm.nih.gov">NCBI</a>
           | 
          <a class="link" href="http://www.nlm.nih.gov">U.S. National Library of Medicine</a>
        </div>
        <div>
          <a class="link" href="http://www.nih.gov">NIH</a>
           | 
          <a class="link" href="http://www.hhs.gov/">Department of Health and Human Services</a>
        </div>
        <div>
          <a class="link" href="about/privacypolicy.html">Privacy Policy</a>
           | 
          <a class="link" href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html">Disclaimer</a>
           | 
          <a class="link" href="http://www.nih.gov/icd/od/foia/index.htm">Freedom of Information Act</a>
        </div>
      </div>
    </div></td></tr></table></body></html><!--host:ipmc3-->

